Source Bioscience (Storage) Limited, trading as Astoriom, is a UK-based life science storage and services provider established in 1903. Registered under company number 00079136 and operating as a limited company, our Nottingham headquarters are located at 1 Orchard Place, NG8 6PX. We operate under SIC code 82990 – Other business support service activities n.e.c., reflecting our comprehensive service offering. Astoriom specializes in providing critical support to the pharmaceutical and biotechnology industries through three core areas: ICH stability storage, biorepository services, and equipment servicing. We maintain a dedicated cGMP facility, ensuring adherence to stringent regulatory standards and offering clients peace of mind regarding sample integrity and traceability. Our expertise centres on the secure and compliant storage of biological samples, supporting drug development programs from early-stage research through to clinical trials and commercialization. We cater to a global clientele, though currently maintain no international presence. Currently, we are recruiting skilled workers, holding a Worker (A) rating. Company size is currently unknown.

Source Bioscience (Storage) Limited, trading as Astoriom, is a UK-based life science storage and services provider established in 1903. Registered under company number 00079136 and operating as a limited company, our Nottingham headquarters are located at 1 Orchard Place, NG8 6PX. We operate under SIC code 82990 – Other business support service activities n.e.c., reflecting our comprehensive service offering. Astoriom specializes in providing critical support to the pharmaceutical and biotechnology industries through three core areas: ICH stability storage, biorepository services, and equipment servicing. We maintain a dedicated cGMP facility, ensuring adherence to stringent regulatory standards and offering clients peace of mind regarding sample integrity and traceability. Our expertise centres on the secure and compliant storage of biological samples, supporting drug development programs from early-stage research through to clinical trials and commercialization. We cater to a global clientele, though currently maintain no international presence. Currently, we are recruiting skilled workers, holding a Worker (A) rating. Company size is currently unknown.